Ping An Biomedical Co EBIT per Share
EBIT per Share of Ping An Biomedical Co (PASW) as of Nov 20, 2026.
Get this data via API
Financial Data API
EBIT per Share
-0.00CNY
YoY
-100.33%
Last updated:
EBIT per Share of Ping An Biomedical Co is 2024 -0.00 CNY. EBIT per Share of Ping An Biomedical Co was 2023 0.03 CNY. It decreases by -100.33% lower compared to the previous year.
The Ping An Biomedical Co EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2022
0.53 CNY
Jan 1, 2023
0.03 CNY
Jan 1, 2024
-0.00 CNY
| YEAR | EBIT per Share | YoY |
|---|---|---|
| -0.00CNY | -100.33% | |
| 0.03CNY | -94.34% | |
| 0.53CNY | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Ping An Biomedical Co Stock analysis
What does Ping An Biomedical Co do? Majestic Ideal Holdings Ltd. generates revenue by providing supply chain management services within the apparel industry. The firm delivers one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. These services cover functions within the supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company employs 7 full-time employees to support these operations.
The business is organized into two distinct segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles, and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. Through these segments, the firm provides end-to-end supply chain solutions to its clients. Ping An Biomedical Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Ping An Biomedical Co stock
On Eulerpool you can find the complete historical development of EBIT per Share Ping An Biomedical Co since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Ping An Biomedical Co
All Key Metrics — Ping An Biomedical Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth